Literature DB >> 272083

Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

M A Schwarz, J U Gutterman, E M Hersh, S P Richman, G M Mavligit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 272083     DOI： 10.1007/bf01556181

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  137 in total

1.  The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection.

Authors:  J G HOWARD; G BIOZZI; B N HALPERN; C STIFFEL; D MOUTON
Journal:  Br J Exp Pathol       Date:  1959-06

2.  Immunotherapy of chronic myelocytic leukemia: effects of different vaccination schedules.

Authors:  J E Sokal; C W Aungst; M Snyderman; G Gomez
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.

Authors:  M C Simmler; G Rameau; M J Chou; G Mathé
Journal:  Isr J Med Sci       Date:  1976 Apr-May

4.  Mycobacterial cell wall components in tumor suppression and regression.

Authors:  E E Ribi; T J Meyer; I Azuma; B Zbar
Journal:  Natl Cancer Inst Monogr       Date:  1973-12

5.  Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin.

Authors:  C Merrin; T Han; E Klein; Z Wajsman; G P Murphy
Journal:  Cancer Chemother Rep       Date:  1975 Jan-Feb

6.  Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.

Authors:  D Farquhar; T L Loo; J U Gutterman; E M Hersh; M A Luna
Journal:  Biochem Pharmacol       Date:  1976-07-01       Impact factor: 5.858

7.  Active specific immunotherapy for ovarian cancer.

Authors:  C N Hudson; J E McHardy; O M Curling; P E English; L Levin; T A Poulton; M Crowther; M Leighton
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

8.  Bacillus Calmette-Guérin vaccination and cancer prevention: a critical review of the human experience.

Authors:  R N Hoover
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

9.  Intralesional BCG in the treatment of metastatic malignant melanoma.

Authors:  M J Mastrangelo; H L Sulit; L M Prehn; R S Bornstein; J W Yarbro; R T Prehn
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

10.  Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  S B Salvin; J S Youngner; W H Lederer
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.